Scottish National Investment Bank

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
2
1 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$110.6M
4 disclosed · full round size, not this investor’s share

By stage

Series B3
Series A1

By primary sector

Biotech2
Healthtech1
Industrial tech1

By country

United Kingdom4

Rounds

4 in all activity
iGii

iGii makes Gii, a three-dimensional porous carbon nanomaterial, and develops industrial sensing, heating and battery-electrode applications from it.

€26.5MSeries B
Lead
Mironid

Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease.

$46MSeries B
Participant
EnteroBiotix

Develops full-spectrum microbiome therapeutics for gastrointestinal diseases including IBS

£19MSeries B
Role not disclosed
Bioliberty

Soft robotics and therapy software for rehabilitation after neurological injury.

£6.2MSeries A initial close
Lead